Baoqing Chen

1.7k total citations · 1 hit paper
45 papers, 996 citations indexed

About

Baoqing Chen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Baoqing Chen has authored 45 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Baoqing Chen's work include Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Baoqing Chen is often cited by papers focused on Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Baoqing Chen collaborates with scholars based in China, United States and Germany. Baoqing Chen's co-authors include Mihnea P. Dragomir, George A. Călin, Qiaoqiao Li, Yang Chen, David Horst, Mian Xi, Shiliang Liu, Yujia Zhu, Hongyan Yang and Ruiqian Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Analytical Chemistry.

In The Last Decade

Baoqing Chen

42 papers receiving 977 citations

Hit Papers

Targeting non-coding RNAs to overcome cancer therapy resi... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting non-coding RNAs to overcome cancer therapy resistance
    2022 268 citations Baoqing Chen, Mihnea P. Dragomir et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baoqing Chen China 15 524 445 222 195 182 45 996
Hun Jung South Korea 18 307 0.6× 167 0.4× 214 1.0× 316 1.6× 219 1.2× 33 867
Weiguo Cao China 14 215 0.4× 205 0.5× 174 0.8× 110 0.6× 81 0.4× 38 581
Takeshi Hisamatsu Japan 16 287 0.5× 150 0.3× 298 1.3× 65 0.3× 52 0.3× 31 820
Chenchen Wang China 16 275 0.5× 185 0.4× 238 1.1× 179 0.9× 166 0.9× 68 821
Hongbing Zhang China 13 323 0.6× 215 0.5× 130 0.6× 140 0.7× 25 0.1× 46 568
Shiheng Zhang China 19 395 0.8× 109 0.2× 168 0.8× 71 0.4× 23 0.1× 28 939
Zi Mei China 15 224 0.4× 73 0.2× 256 1.2× 62 0.3× 46 0.3× 29 851
Roberta Libener Italy 21 259 0.5× 99 0.2× 278 1.3× 687 3.5× 157 0.9× 60 1.3k
Yuichiro Kubo Japan 16 102 0.2× 105 0.2× 175 0.8× 108 0.6× 224 1.2× 41 664

Countries citing papers authored by Baoqing Chen

Since Specialization
Citations

This map shows the geographic impact of Baoqing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoqing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoqing Chen more than expected).

Fields of papers citing papers by Baoqing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoqing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoqing Chen. The network helps show where Baoqing Chen may publish in the future.

Co-authorship network of co-authors of Baoqing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Baoqing Chen. A scholar is included among the top collaborators of Baoqing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baoqing Chen. Baoqing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Baoqing, et al.. (2025). Volatile organic compounds in exhaled breath: Applications in cancer diagnosis and predicting treatment efficacy. PubMed. 3(5). 411–419. 3 indexed citations
2.
Gu, Yu, Hongbing Qiu, & Baoqing Chen. (2025). AoI-Minimal Task Assignment and Trajectory Optimization in Multi-UAV-Assisted Wireless Powered IoT Networks. Drones. 9(2). 90–90. 1 indexed citations
3.
Zhang, Chao, Sha Zhou, Shiliang Liu, et al.. (2025). RNF217-KEAP1-NRF2 feedback loop confers therapeutic resistance by inhibiting ferroptosis in esophageal squamous cell carcinoma. Drug Resistance Updates. 83. 101296–101296.
4.
Chen, Baoqing, et al.. (2024). Joint Spatio-Temporal-Frequency Representation Learning for Improved Sound Event Localization and Detection. Sensors. 24(18). 6090–6090. 1 indexed citations
5.
Chen, Baoqing, Shiliang Liu, Yujia Zhu, et al.. (2024). Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab. Nature Communications. 15(1). 1919–1919. 14 indexed citations
6.
7.
8.
9.
10.
Chen, Rui, Qianwen Liu, Qiaoqiao Li, et al.. (2023). A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901). EClinicalMedicine. 62. 102118–102118. 23 indexed citations
11.
Zhu, Yujia, Jing Wen, Qiaoqiao Li, et al.. (2023). Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial. The Lancet Oncology. 24(4). 371–382. 44 indexed citations
12.
Chen, Baoqing, Jun Zhang, Jinhan Zhu, et al.. (2023). Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy. The Oncologist. 28(8). e606–e616. 7 indexed citations
13.
Liang, Zhaohui, Kongjia Luo, Yuting Wang, et al.. (2022). Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery. Annals of Surgical Oncology. 30(1). 529–538. 2 indexed citations
14.
Chen, Baoqing, Mihnea P. Dragomir, Yang Chen, et al.. (2022). Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduction and Targeted Therapy. 7(1). 121–121. 268 indexed citations breakdown →
15.
Chen, Baoqing, Meiling Deng, Yang Chen, et al.. (2021). High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis. Radiotherapy and Oncology. 158. 191–199. 22 indexed citations
16.
Chen, Baoqing, Han Yang, Qiaoqiao Li, et al.. (2019). Radiotherapy for small cell carcinoma of the esophagus: outcomes and prognostic factors from a retrospective study. Radiation Oncology. 14(1). 210–210. 14 indexed citations
17.
Dragomir, Mihnea P., et al.. (2018). Key questions about the checkpoint blockade-are microRNAs an answer?. Cancer Biology and Medicine. 15(2). 103–103. 37 indexed citations
18.
Chen, Baoqing, Feifei Na, Hui Yang, et al.. (2017). Ethyl pyruvate alleviates radiation-induced lung injury in mice. Biomedicine & Pharmacotherapy. 92. 468–478. 28 indexed citations
19.
Deng, Lei, Balázs Győrffy, Baoqing Chen, et al.. (2015). Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non–Small-Cell Lung Cancer: Results from a Large and Pooled Microarray Database. Journal of Thoracic Oncology. 10(7). 1020–1026. 35 indexed citations
20.
Shen, Jiantong, Youping Li, Taixiang Wu, et al.. (2012). Subject, function, and trend in medical ethics research: a comparative study of Chinese and non‐Chinese literature using bibliometrics. Journal of Evidence-Based Medicine. 5(2). 57–65. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hun Jung Breakdown of academic impact, for papers by Weiguo Cao Breakdown of academic impact, for papers by Takeshi Hisamatsu Breakdown of academic impact, for papers by Chenchen Wang Breakdown of academic impact, for papers by Hongbing Zhang Breakdown of academic impact, for papers by Shiheng Zhang Breakdown of academic impact, for papers by Zi Mei Breakdown of academic impact, for papers by Roberta Libener Breakdown of academic impact, for papers by Yuichiro Kubo
Rankless by CCL
2026